OneMedNet Partners with Leading Medical Center to Accelerate Diagnostic and Treatment Solutions Using iRWD

Date:

OneMedNet, the leading curator of regulatory-grade imaging Real World Data (RWD), has announced a new partnership with a renowned research medical center to accelerate the development of diagnostic and treatment solutions. This collaboration aims to leverage OneMedNet’s iRWD platform, enabling life science innovators in pharmaceutical, AI, medical device, and clinical research organizations to effectively utilize real-world data for various purposes including discovery, development, regulatory approval, and post-market surveillance.

According to Aaron Green, President of OneMedNet, the challenge for life science companies lies not in utilizing RWD in their processes, but in obtaining highly specific data that meets all required attributes. OneMedNet has been successfully identifying, indexing, and de-identifying imaging data for over a decade, providing healthcare providers and life sciences with the most current regulatory-grade data.

The engagement of healthcare providers is crucial for unleashing the potential of this essential data, which fuels technology and clinical advancement. Academic tertiary centers offer significant data diversity, which is highly valued by regulatory authorities like the Food and Drug Administration. Therefore, the partnership with a leading research medical center adds to OneMedNet’s vast network, which already consists of over 200 healthcare systems and providers. This expansion brings the total number of research centers and institutions in their network to 20, including a top-ranked hospital with a leading cancer center.

Founded in 2009, OneMedNet specializes in solutions that unlock the value within the clinical image archives of healthcare providers. With its iRWD solution, the company securely de-identifies, searches, and curates data archives, bringing a wealth of internal and third-party research opportunities to providers. Leveraging its extensive network and cutting-edge technology, OneMedNet meets the rigorous requirements of regulatory-grade RWD in the life science industry.

See also  Microsoft CEO Satya Nadella Launches Ambitious AI Training Program to Empower Indian Youth

In summary, OneMedNet’s partnership with a leading research medical center is set to accelerate the development of diagnostic and treatment solutions using their iRWD platform. This collaboration will provide life science innovators with access to critical real-world data, facilitating their research, development, and regulatory processes. With its comprehensive network and expertise, OneMedNet is well-positioned to support the healthcare industry and meet the stringent demands of regulatory authorities.

Frequently Asked Questions (FAQs) Related to the Above News

What is OneMedNet?

OneMedNet is a company specializing in solutions that unlock the value within the clinical image archives of healthcare providers. They curate regulatory-grade imaging Real World Data (RWD) and provide access to this data through their iRWD platform.

What is the purpose of OneMedNet's partnership with a research medical center?

The partnership aims to accelerate the development of diagnostic and treatment solutions by leveraging OneMedNet's iRWD platform. Through this collaboration, life science innovators can effectively utilize real-world data for purposes such as discovery, development, regulatory approval, and post-market surveillance.

What challenges do life science companies face when utilizing real-world data?

The main challenge for life science companies is obtaining highly specific data that meets all required attributes. OneMedNet addresses this challenge by identifying, indexing, and de-identifying imaging data to provide healthcare providers and life sciences with regulatory-grade data.

Why is the engagement of healthcare providers crucial in utilizing real-world data?

Healthcare providers play a vital role in unleashing the potential of real-world data, as it fuels technology and clinical advancement. Academic tertiary centers, like the research medical center partnering with OneMedNet, offer significant data diversity, which is highly valued by regulatory authorities such as the FDA.

How does OneMedNet's extensive network benefit life science innovators?

OneMedNet already has a vast network consisting of over 200 healthcare systems and providers. The partnership with the research medical center adds to this network, bringing the total number of research centers and institutions to 20. This allows life science innovators to access critical real-world data and enhances their research, development, and regulatory processes.

What is the iRWD platform offered by OneMedNet?

The iRWD platform is a secure solution provided by OneMedNet that de-identifies, searches, and curates clinical image archives. It unlocks the potential of regulatory-grade Real World Data (RWD) for healthcare providers and life science organizations, enabling them to leverage this data for various purposes.

How does OneMedNet meet the requirements of regulatory-grade RWD?

OneMedNet meets the rigorous requirements of regulatory-grade Real World Data (RWD) by utilizing their extensive network and cutting-edge technology. They specialize in identifying, indexing, and de-identifying imaging data, ensuring that it meets all necessary attributes for regulatory approval and usage in the life science industry.

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.